Spinocerebellar Ataxia: miRNAs

microRNAs (miRNAs) are key regulatory RNAs that control modulate gene expression in various biological processes and human diseases such as Spinocerebellar Ataxia. Here are the latest discoveries pertaining to miRNAs and this disease.

June 19, 2019
Open Access

Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia

Movement Disorders : Official Journal of the Movement Disorder Society
Alhassane DialloSophie Tezenas du Montcel
October 2, 2019

A neuroscientific approach to increase gender equality

Nature Human Behaviour
Christiane SchreiweisVioletta Zujovic
January 3, 2019
Open Access

A new MRI marker of ataxia with oculomotor apraxia

European Journal of Radiology
Solène RonsinCaroline Tilikete
December 16, 2019
Review

Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies

Neuroscience and Biobehavioral Reviews
Janna KraheSandro Romanzetti
November 27, 2018
Review

Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view

F1000Research
Giulia CoarelliAlexandra Durr
August 14, 2019

Association of CAG Repeats With Long-term Progression in Huntington Disease

JAMA Neurology
Douglas R LangbehnTRACK-HD and Track-On HD Groups
January 10, 2019

Cell Death Mechanisms in a Mouse Model of Retinal Degeneration in Spinocerebellar Ataxia 7

Neuroscience
Cecile LebonAlicia Torriglia
November 27, 2019
Preprint
Open Access

Neurofilaments as blood biomarkers at the preataxic and ataxic stage of spinocerebellar ataxia type 3: a cross-species analysis in humans and mice

MedRxiv : the Preprint Server for Health Sciences
Carlo WilkeL. Schoels
July 17, 2020

Autophagy and Polyglutamine Disease

Advances in Experimental Medicine and Biology
Haigang RenGuanghui Wang
July 28, 2020
Open Access

Author's Reply to Peverill: "Predictors of Left Ventricular Dysfunction in Friedreich's Ataxia in a 16-Year Observational Study"

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Francoise PoussetAlexandra Durr
August 27, 2019

Oral mobility reflects rate of progression in advanced Friedreich's ataxia

Annals of Clinical and Translational Neurology
Stéphanie BorelAlexandra Durr
February 19, 2019

Contemporary Dance Practice Improves Motor Function and Body Representation in Huntington's Disease: A Pilot Study

Journal of Huntington's Disease
Iris TrinklerAlexandra Durr
February 18, 2020

Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease

Psychological Medicine
S C AndrewsTRACK-HD Investigators
July 1, 2020
Open Access

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia

Acta Neuropathologica Communications
Kunie AndoJean-Pierre Brion
November 26, 2019

Accelerated 129 Xe MRI morphometry of terminal airspace enlargement: Feasibility in volunteers and those with alpha-1 antitrypsin deficiency

Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine
Alexei OuriadovGrace Parraga
April 19, 2019

A SCA7 premutation may be a novel Mendelian modifier of MS course: A case report

Multiple Sclerosis and Related Disorders
Christina SundalOluf Andersen
December 20, 2019
Open Access

Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms

Brain : a Journal of Neurology
Vincent HuinIsabelle Le Ber

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/spinocerebellar-ataxia-mirnas/c3e674fa-59c9-4c12-bf09-160beb819f9e